We strive to support our portfolio companies over the longterm, leveraging our global network and providing strategic support with scientific, technical, and market knowledge to maximize success. We Venture Capital focuses on investing in innovative health and biotechnology companies, including sectors such as therapeutic drug monitoring, genomics tertiary analysis, dried blood spot, and sepsis diagnosis. The firm believes in technological advancement as a means to improve patient outcomes and revolutionize healthcare.